We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-10.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$501M
AUM Growth
+$25.6M
Cap. Flow
+$93.2M
Cap. Flow %
18.6%
Top 10 Hldgs %
66.14%
Holding
135
New
29
Increased
35
Reduced
10
Closed
61

Top Buys

Rank Stock Value
1
ICUI icon
ICU Medical
ICUI
+$5.87M
2
INSP icon
Inspire Medical Systems
INSP
+$5.07M
3
GH icon
Guardant Health
GH
+$4.07M
4
SIBN icon
SI-BONE Inc
SIBN
+$4.06M
5
NSTG
NanoString Technologies, Inc.
NSTG
+$3.8M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$8.34M
2
MDT icon
Medtronic
MDT
+$7.57M
3
AZTA icon
Azenta
AZTA
+$5.7M
4
CNC icon
Centene
CNC
+$5.49M
5
ZBH icon
Zimmer Biomet
ZBH
+$5.26M

Sector Composition

Rank Sector Weight
1 Healthcare 28.11%
2 Industrials 0.17%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
101
Pacific Biosciences
PACB
$354M
– –
-303,734
Closed -$1.64M
PBH icon
102
PUT
Prestige Consumer Healthcare
PBH
$2.54B
– –
-50,000
Closed -$1.9M
QGEN icon
103
CALL
Qiagen
QGEN
$8.81B
– –
-37,722
Closed -$1.51M
REGN icon
104
CALL
Regeneron Pharmaceuticals
REGN
$82.1B
– –
-10,000
Closed -$4.04M
RNAC icon
105
Cartesian Therapeutics
RNAC
$260M
– –
-1,940
Closed -$905K
SMH icon
106
PUT
VanEck Semiconductor ETF
SMH
$70.6B
– –
-90,000
Closed -$4.79M
SNDX icon
107
Syndax Pharmaceuticals
SNDX
$1.81B
– –
-100,000
Closed -$548K
TFX icon
108
PUT
Teleflex
TFX
$5.91B
– –
-10,000
Closed -$2.66M
TMO icon
109
PUT
Thermo Fisher Scientific
TMO
$224B
– –
-12,500
Closed -$3.05M
VTRS icon
110
CALL
Viatris
VTRS
$18.7B
– –
-50,000
Closed -$1.83M
XBI icon
111
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
– –
-50,000
Closed -$4.79M
YMAB
112
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-22,350
Closed -$594K
ZBH icon
113
CALL
Zimmer Biomet
ZBH
$18.5B
– –
-51,500
Closed -$6.57M
ZBH icon
114
Zimmer Biomet
ZBH
$18.5B
– –
-41,200
Closed -$5.26M
ITCI
115
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-168,100
Closed -$3.65M
GRTS
116
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-75,000
Closed -$1.07M
EIGR
117
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-1,350
Closed -$486K
MRTX
118
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-50,000
Closed -$2.35M
SYNH
119
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-91,120
Closed -$4.7M
MTEM
120
DELISTED
Molecular Templates, Inc.
MTEM
– –
-6,461
Closed -$522K
SPPI
121
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-50,000
Closed -$840K
SPPI
122
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-100,000
Closed -$1.68M
OBSV
123
DELISTED
ObsEva SA Ordinary Shares
OBSV
– –
-50,622
Closed -$913K
IVC
124
DELISTED
Invacare Corporation
IVC
– –
-100,000
Closed -$1.46M
AERI
125
CALL
DELISTED
Aerie Pharmaceuticals
AERI
– –
-75,000
Closed -$4.62M
2 3 4
5
6

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2018 Portfolio in Review

As of Q4 2018, Pura Vida Investments held 135 positions worth $501M, up 5.4% from $475M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Pura Vida Investments deployed $93.2M of net new capital in Q4 2018, opening 29 new positions and adding to 35 existing holdings. Its largest new stake was Guardant Health: 110,363 shares worth $4.15M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 35% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Boston Scientific, an estimated $8.34M trimmed.

  • Pura Vida Investments's largest Q4 2018 buy was Guardant Health: 110,363 shares worth $4.15M.
  • Pura Vida Investments added most to ICU Medical in Q4 2018, an estimated $5.87M increase.
  • Pura Vida Investments's biggest Q4 2018 reduction was Boston Scientific, cutting an estimated $8.34M.
  • Pura Vida Investments fully exited Medtronic in Q4 2018, selling an estimated $7.57M.
  • Pura Vida Investments's ten largest holdings make up 66% of its $501M portfolio in Q4 2018.
  • Pura Vida Investments opened 29 new positions and closed 61 in Q4 2018.
  • Pura Vida Investments's portfolio value rose 5.4% quarter-over-quarter to $501M.

Based on Pura Vida Investments's 13F filing for Q4 2018, filed 14 Feb 2019.